5BPK
 
 | Varying binding modes of inhibitors and structural differences in the binding pockets of different gamma-glutamyltranspeptidases | Descriptor: | (2S)-amino[(5S)-4,5-dihydro-1,2-oxazol-5-yl]acetic acid, 1,2-ETHANEDIOL, Gamma-glutamyltranspeptidase (Ggt) | Authors: | Bolz, C, Bach, N.C, Meyer, H, Mueller, G, Dawidowski, M, Popowicz, G, Sieber, S.A, Skerra, A, Gerhard, M. | Deposit date: | 2015-05-28 | Release date: | 2016-05-18 | Last modified: | 2024-01-10 | Method: | X-RAY DIFFRACTION (1.49 Å) | Cite: | Varying binding modes of inhibitors and structural differences in the binding pockets of different gamma-glutamyltranspeptidases To Be Published
|
|
6GBH
 
 | Helicobacter pylori adhesin HopQ type II bound to the N-terminal domain of human CEACAM1 | Descriptor: | Carcinoembryonic antigen-related cell adhesion molecule 1, HopQ, SULFATE ION | Authors: | Moonens, K, Kruse, T, Gerhard, M, Remaut, H. | Deposit date: | 2018-04-13 | Release date: | 2018-06-27 | Last modified: | 2024-11-06 | Method: | X-RAY DIFFRACTION (2.59 Å) | Cite: | Helicobacter pyloriadhesin HopQ disruptstransdimerization in human CEACAMs. EMBO J., 37, 2018
|
|
6GBG
 
 | Helicobacter pylori adhesin HopQ type I bound to the N-terminal domain of human CEACAM1 | Descriptor: | BROMIDE ION, Carcinoembryonic antigen-related cell adhesion molecule 1, Outer membrane protein | Authors: | Moonens, K, Kruse, T, Gerhard, M, Remaut, H. | Deposit date: | 2018-04-13 | Release date: | 2018-06-27 | Last modified: | 2024-11-20 | Method: | X-RAY DIFFRACTION (2.8 Å) | Cite: | Helicobacter pyloriadhesin HopQ disruptstransdimerization in human CEACAMs. EMBO J., 37, 2018
|
|
9F5V
 
 | Crystal structure of thiol peroxidase from Helicobacter pylori (HpTx, reduced) | Descriptor: | Thiol peroxidase | Authors: | Fiedler, M.K, Gong, R, Fuchs, S, Rox, K, Friedrich, V, Pfeiffer, D, Reinhardt, T, Mibus, C, Huber, M, Hess, C, Mejias-Luque, R, Gerhard, M, Groll, M, Sieber, S.A. | Deposit date: | 2024-04-30 | Release date: | 2025-05-14 | Method: | X-RAY DIFFRACTION (1.75 Å) | Cite: | 5-Nitroimidazole ethers boost anti-Helicobacter pylori activity via a dual mode of action and effectively eradicate infections in vivo to be published
|
|
9F64
 
 | Crystal structure of thiol peroxidase mutant (C94A) in complex with Metro* (H. pylori | Descriptor: | 1,2-ETHANEDIOL, 2-(5-azanyl-2-methyl-imidazol-1-yl)ethanol, SODIUM ION, ... | Authors: | Fiedler, M.K, Gong, R, Fuchs, S, Rox, K, Friedrich, V, Pfeiffer, D, Reinhardt, T, Mibus, C, Huber, M, Hess, C, Mejias-Luque, R, Gerhard, M, Groll, M, Sieber, S.A. | Deposit date: | 2024-04-30 | Release date: | 2025-05-14 | Method: | X-RAY DIFFRACTION (1.75 Å) | Cite: | 5-Nitroimidazole ethers boost anti-Helicobacter pylori activity via a dual mode of action and effectively eradicate infections in vivo to be published
|
|
9F65
 
 | Crystal structure of thiol peroxidase mutant (C94A) in complex with Metro-P3* (H. pylori) | Descriptor: | 3-methyl-2-(prop-2-ynoxymethyl)imidazol-4-amine, Thiol peroxidase | Authors: | Fiedler, M.K, Gong, R, Fuchs, S, Rox, K, Friedrich, V, Pfeiffer, D, Reinhardt, T, Mibus, C, Huber, M, Hess, C, Mejias-Luque, R, Gerhard, M, Groll, M, Sieber, S.A. | Deposit date: | 2024-04-30 | Release date: | 2025-05-14 | Method: | X-RAY DIFFRACTION (1.95 Å) | Cite: | 5-Nitroimidazole ethers boost anti-Helicobacter pylori activity via a dual mode of action and effectively eradicate infections in vivo to be published
|
|
5LP2
 
 | |